grade
anhydrous
product line
ReagentPlus®, Redi-Dri™
assay
99%
form
powder or crystals
quality
free-flowing
pH
6
mp
605 °C (lit.)
SMILES string
[Li+].[Cl-]
InChI
1S/ClH.Li/h1H;/q;+1/p-1
InChI key
KWGKDLIKAYFUFQ-UHFFFAOYSA-M
General description
Redi-Dri™ 技术消除了结块，也不需要复杂的程序来保持盐的自由流动。保持盐干燥有助于改进结果，提供准确的测量和更容易处理的盐和缓冲液。Redi-Dri™ 不需要在烤箱或干燥器中干燥盐，也不需要手动将盐分开，可以确保盐在几个月内保持易于使用，而无需担心防结块剂。即使在反复打开后，你也可以确信你的结果总是准确的。Redi-Dri™ 可以节省你的时间、精力和金钱，让你的盐可以使用更长时间!
Application
氯化锂可以在无溶剂的情况下用作催化剂：
- 醛和酮与氰三烷基硅烷的氰硅化反应，以提供硅化氰醇。
- 通过微波辅助克莱森-施密特缩合制备 α, β-不饱和酮。
- 添加剂，通过芳基碘化物与芳基锡烷的 Pd 催化 Stille 偶联合成相应联苯。
- 催化剂，通过芳基甲基醚的化学和区域选择性去甲基化形成相应的苯酚产物。
Features and Benefits
- 提高效率–免除需要松散硬化粉末的时间和精力
- 更加安全–避免使用工具大力敲碎团块的风险
- 更加经济–制备和溶剂化速度更快，提高效率并节约成本
- 质量保证–经过专业检测的出色品质，无抗结剂添加
- 灵活的用量选择–有从研究到放大级别的用量规格可供选择
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under 氯化锂
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2
存储类别
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
商品
Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.
Giovanna Cutrone et al.
Carbohydrate polymers, 223, 115085-115085 (2019-08-21)
Nanoparticles made of metal-organic frameworks (nanoMOFs) are becoming of increasing interest as drug carriers. However, engineered coatings such as poly(ethylene glycol) (PEG) based ones are required to prevent nanoMOFs recognition and clearance by the innate immune system, a prerequisite for
Alessandro Di Maio et al.
EvoDevo, 6, 17-17 (2015-07-15)
Wnt signaling is one of the earliest and most highly conserved regulatory pathways for the establishment of the body axes during regeneration and early development. In regeneration, body axes determination occurs independently of tissue rearrangement and early developmental cues. Modulation
Ted M Hsu et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(2), 327-337 (2014-07-19)
Glucagon-like peptide-1 (GLP-1) is produced in the small intestines and in nucleus tractus solitarius (NTS) neurons. Activation of central GLP-1 receptors (GLP-1Rs) reduces feeding and body weight. The neural circuits mediating these effects are only partially understood. Here we investigate
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 793620-1KG | 04061832951713 |
| 793620-2.5KG | 04061832951737 |
| 793620-100G | 04061832951669 |
| 793620-500G | 04061832951768 |